Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN

Delayed Quote. Delayed  - 08/26 10:00:00 pm
402.97 USD   +0.68%
08/22 S&P 500 MOVERS : Mro, regn
08/22 REGENERON PHARM : Announces Agreement with BARDA for the Manufacturi..
08/05DJREGENERON PHARM : Revenue Jumps on Sales of Eye Treatment Eylea -- U..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/22/2016 08/23/2016 08/24/2016 08/25/2016 08/26/2016 Date
418.65(c) 420.61(c) 405.25(c) 400.25(c) 402.97(c) Last
907 535 452 161 605 157 830 464 662 730 Volume
+3.55% +0.47% -3.65% -1.23% +0.68% Change
More quotes
Financials ($)
Sales 2016 5 062 M
EBIT 2016 1 819 M
Net income 2016 731 M
Finance 2016 961 M
Yield 2016 -
Sales 2017 6 005 M
EBIT 2017 2 234 M
Net income 2017 1 092 M
Finance 2017 1 535 M
Yield 2017 -
P/E ratio 2016 66,19
P/E ratio 2017 45,41
EV / Sales2016 8,19x
EV / Sales2017 6,81x
Capitalization 42 431 M
More Financials
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company.It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.The company involves in marketing medicines for eye diseases, colorectal cancer and a rare inflammatory... 
More about the company
Surperformance© ratings of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More Ratings
Latest news on REGENERON PHARMACEUTICALS
08/25 REGENERON PHARMACEUTICALS : Patent Issued for Stable Liquid Formulations of Dime..
08/25 REGENERON PHARMACEUTICALS : Patent Application Titled "Aseptic Drug Delivery Sys..
08/25 REGENERON PHARMACEUTICALS : Researchers Submit Patent Application, "Shoulder Ada..
08/25 REGENERON PHARMACEUTICALS : Patent Issued for Methods and Compositions for Gener..
08/22 S&P 500 MOVERS : Mro, regn
08/22 REGENERON PHARMACEUTICALS : Announces Agreement with BARDA for the Manufacturing..
08/18 REGENERON PHARMACEUTICALS : Findings from Regeneron Pharmaceuticals Inc. Update ..
08/18 REGENERON PHARMACEUTICALS : U.S. Patents Awarded to Inventors in New Jersey (Aug..
08/18 REGENERON PHARMACEUTICALS : Patent Issued for Promoter-Regulated Differentiation..
08/18 REGENERON PHARMACEUTICALS : Patent Issued for Methods of Inhibiting Tumor Growth..
More news
Sector news : Bio Therapeutic Drugs
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/22DJPfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
08/25 88 Stock Picks For The Next 30 Years (Or More)
08/25 Shocked! Mylan, Biotechs Swoon After Hillary's Statement
08/23 Who's Next After Medivation?
08/22 Amgen undeterred with cholesterol fighter Repatha; 11 abstracts on tap for up..
08/22 Regeneron inks development deal with BARDA for MERS treatment candidates
Advertisement
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Technical analysis trends REGENERON PHARMAC...
Short TermMid-TermLong Term
TrendsNeutralBullishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 467 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Leonard S. Schleifer President, Chief Executive Officer & Director
P. Roy Vagelos Chairman
Robert E. Landry Chief Financial Officer & Senior VP-Finance
George Damis Yancopoulos Director & Chief Scientific Officer
Neil Stahl Executive VP-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
REGENERON PHARMACEUTIC..-25.77%42 431
AMGEN, INC.5.94%128 696
GILEAD SCIENCES, INC.-21.17%105 269
CELGENE CORPORATION-9.16%84 325
VERTEX PHARMACEUTICALS..-22.84%24 057
ACTELION LTD17.62%18 205
More Results